Cedrus Pharmaceutical Private Limited
About Cedrus Pharmaceutical Private Limited
Data last updated:
Cedrus Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC106263. Its GSTIN is 06AAHCC6669D1ZK (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Prateek Singh and Mayank.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 110 D Block – 28 Lig Sector – 99 G.B.Nagar, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.29 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹12.29 Lakh (net margin 21.4%) and EBITDA of ₹16.7 Lakh (EBITDA margin 29.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address110 D Block – 28 Lig Sector – 99 G.B.Nagar, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cedrus Pharmaceutical Private Limited
The main business activity of Cedrus Pharmaceutical is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cedrus Pharmaceutical Private Limited FY 2025 filings available
Cedrus Pharmaceutical Private Limited reported revenue of ₹57.29 Lakh (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Cedrus Pharmaceutical Private Limited
Revenue fell 1% in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cedrus Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.29 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cedrus Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 21.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cedrus Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elimo Technologies Private Limited | ₹57.33 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Dravya Agrovet Private Limited | ₹57.32 Lakh (FY 2025) | •••• | •••• | 184.0% | •••• | Kolkata, West Bengal, India |
| Fernwaypark Inn and Suites Private Limited | ₹57.32 Lakh (FY 2021) | •••• | •••• | 1333.0% | •••• | New Delhi, Delhi, India |
| Vigada Care Private Limited | ₹57.31 Lakh (FY 2023) | •••• | •••• | 133.0% | •••• | New Delhi, Delhi, India |
| Gdas Concrete Solution Private Limited | ₹57.3 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Varanasi, Uttar Pradesh, India |
| Cedrus Pharmaceutical Private Limited this company | ₹57.29 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Noida, Uttar Pradesh, India |
| Odini Products Private Limited | ₹57.28 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Ballabgarh, Haryana, India |
| Cursor Control Private Limited | ₹57.27 Lakh (FY 2024) | •••• | •••• | -35.0% | •••• | Chennai, Tamil Nadu, India |
| Rove Electric Private Limited | ₹57.27 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | G N Mills, Tamil Nadu, India |
| Allison Exports Private Limited | ₹57.27 Lakh (FY 2024) | •••• | •••• | 167.0% | •••• | Chennai, Tamil Nadu, India |
| Slam Dunk Styles Private Limited | ₹57.27 Lakh (FY 2023) | •••• | •••• | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Cedrus Pharmaceutical by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Singh Also directs: Hueframe Technologies Private Limited | Director | 16 Jul 2018 | 8 Years 2 Months | Current |
| Mayank | Director | 12 May 2022 | 4 Years 4 Months | Current |
Ownership and Shareholding of Cedrus Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cedrus Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Cedrus Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Mayank ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Cedrus Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cedrus Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cedrus Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCC6669D1ZK | Haryana | Active | 02 Jul 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cedrus Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cedrus Pharmaceutical Private Limited
Cedrus Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 July 2018 (8+ years old) and is registered under CIN U51909UP2018PTC106263.
Cedrus Pharmaceutical reported revenue of ₹57.29 Lakh for FY 2025 (down 1% YoY).
Cedrus Pharmaceutical has 2 current directors:
- Prateek Singh - Director
- Mayank - Director
Cedrus Pharmaceutical reported a net profit of ₹12.29 Lakh (net margin 21.4%) and EBITDA of ₹16.7 Lakh (EBITDA margin 29.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Cedrus Pharmaceutical is 06AAHCC6669D1ZK, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cedrus Pharmaceutical is U51909UP2018PTC106263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cedrus Pharmaceutical was incorporated on 16 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Cedrus Pharmaceutical by revenue are Elimo Technologies Private Limited, Dravya Agrovet Private Limited, Fernwaypark Inn and Suites Private Limited, Vigada Care Private Limited, Gdas Concrete Solution Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Mayank ceased to be Additional Director on 30 Sep 2022. Sanjeev Ranjan ceased to be Director on 16 May 2022. Mayank was appointed as Director on 12 May 2022. Cedrus Pharmaceutical has 4 board changes on record in total.
The registered office of Cedrus Pharmaceutical is at 110 D Block – 28 Lig Sector – 99 G.B.Nagar, Noida, Uttar Pradesh, India – 201301.
Cedrus Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.